176 related articles for article (PubMed ID: 9702788)
1. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients.
Rosenbaum C; Kluwe L; Mautner VF; Friedrich RE; Müller HW; Hanemann CO
Neurobiol Dis; 1998 Jul; 5(1):55-64. PubMed ID: 9702788
[TBL] [Abstract][Full Text] [Related]
2. Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidine.
Rosenbaum C; Kamleiter M; Grafe P; Kluwe L; Mautner V; Müller HW; Hanemann CO
Neurobiol Dis; 2000 Aug; 7(4):483-91. PubMed ID: 10964617
[TBL] [Abstract][Full Text] [Related]
3. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
4. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
Sanson M
Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression between human schwannoma and control Schwann cells.
Hanemann CO; Bartelt-Kirbach B; Diebold R; Kämpchen K; Langmesser S; Utermark T
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):605-14. PubMed ID: 17083475
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
Huynh DP; Pulst SM
Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2.
Hung G; Li X; Faudoa R; Xeu Z; Kluwe L; Rhim JS; Slattery W; Lim D
Int J Oncol; 2002 Mar; 20(3):475-82. PubMed ID: 11836557
[TBL] [Abstract][Full Text] [Related]
8. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells.
Pelton PD; Sherman LS; Rizvi TA; Marchionni MA; Wood P; Friedman RA; Ratner N
Oncogene; 1998 Oct; 17(17):2195-209. PubMed ID: 9811451
[TBL] [Abstract][Full Text] [Related]
9. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
10. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
11. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis.
Badache A; Muja N; De Vries GH
Oncogene; 1998 Aug; 17(6):795-800. PubMed ID: 9715282
[TBL] [Abstract][Full Text] [Related]
12. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.
Lallemand D; Manent J; Couvelard A; Watilliaux A; Siena M; Chareyre F; Lampin A; Niwa-Kawakita M; Kalamarides M; Giovannini M
Oncogene; 2009 Feb; 28(6):854-65. PubMed ID: 19029950
[TBL] [Abstract][Full Text] [Related]
13. Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells.
Obremski VJ; Hall AM; Fernandez-Valle C
J Neurobiol; 1998 Dec; 37(4):487-501. PubMed ID: 9858254
[TBL] [Abstract][Full Text] [Related]
14. Voltage-dependent membrane currents of cultured human neurofibromatosis type 2 Schwann cells.
Kamleiter M; Hanemann CO; Kluwe L; Rosenbaum C; Wosch S; Mautner VF; Müller HW; Grafe P
Glia; 1998 Nov; 24(3):313-22. PubMed ID: 9775982
[TBL] [Abstract][Full Text] [Related]
15. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
[TBL] [Abstract][Full Text] [Related]
16. Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
Utermark T; Alekov A; Lerche H; Abramowski V; Giovannini M; Hanemann CO
Cancer; 2003 Apr; 97(8):1955-62. PubMed ID: 12673723
[TBL] [Abstract][Full Text] [Related]
17. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients.
Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L
Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265
[TBL] [Abstract][Full Text] [Related]
18. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
19. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene.
Sherman L; Jacoby LB; Lampe J; Pelton P; Aguzzi A; Herrlich P; Ponta H
Cancer Res; 1997 Nov; 57(21):4889-97. PubMed ID: 9354454
[TBL] [Abstract][Full Text] [Related]
20. Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells.
Flaiz C; Utermark T; Parkinson DB; Poetsch A; Hanemann CO
Glia; 2008 Apr; 56(5):506-15. PubMed ID: 18240308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]